The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population
Authors:
Open Access
- 29 June 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Abstract
The validity of dementia diagnostic criteria depends on their ability to distinguish dementia symptoms from pre-existing cognitive impairments. The study aimed to assess inter-rater reliability and concurrent validity of DSM-5 criteria for neurocognitive disorder in Down syndrome. The utility of mild neurocognitive disorder as a distinct diagnostic category, and the association between clinical symptoms and neurodegenerative changes represented by the plasma biomarker neurofilament light were also examined. 165 adults with Down syndrome were included. Two clinicians independently applied clinical judgement, DSM-IV, ICD-10 and DSM-5 criteria for dementia (or neurocognitive disorder) to each case. Inter-rater reliability and concurrent validity were analysed using the kappa statistic. Plasma neurofilament light concentrations were measured for 55 participants as a marker of neurodegeneration and between group comparisons calculated. All diagnostic criteria showed good inter-rater reliability apart from mild neurocognitive disorder which was moderate (k = 0.494). DSM- 5 criteria had substantial concurrence with clinical judgement (k = 0.855). When compared to the no neurocognitive disorder group, average neurofilament light concentrations were higher in both the mild and major neurocognitive disorder groups. DSM-5 neurocognitive disorder criteria can be used reliably in a Down syndrome population and has higher concurrence with clinical judgement than the older DSM-IV and ICD-10 criteria. Whilst the inter-rater reliability of the mild neurocognitive disorder criteria was modest, it does appear to identify people in an early stage of dementia with underlying neurodegenerative changes, represented by higher average NfL levels.Keywords
Funding Information
- Alzheimer’s Society Fellowship (AS-CP-18-0020)
- NIHR
- Jerome Lejeune Foundation - Horizon21
- Medical Research Council (MRC S011277/1, MR/S005145/1 (from Centres of Excellence in Neurodegeneration research) and MR/R024901/1 (from JPND))
- National Institute for Health Research networks
- Wellcome Trust Strategic Award (098330/Z/12/Z)
This publication has 28 references indexed in Scilit:
- Aging related cognitive changes associated with Alzheimer's disease in Down syndromeAnnals of Clinical and Translational Neurology, 2018
- A prospective 20‐year longitudinal follow‐up of dementia in persons with Down syndromeJournal of Intellectual Disability Research, 2017
- The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal StudiesNeuropsychology Review, 2017
- Dementia in Down's syndromeThe Lancet Neurology, 2016
- Mild Neurocognitive DisorderHarvard Review of Psychiatry, 2015
- A genetic cause of Alzheimer disease: mechanistic insights from Down syndromeNature Reviews Neuroscience, 2015
- Dementia diagnostic criteria in Down syndromeInternational Journal of Geriatric Psychiatry, 2014
- Classifying neurocognitive disorders: the DSM-5 approachNature Reviews Neurology, 2014
- Diagnostic and Statistical Manual of Mental Disorders2013
- Diagnosis of dementia in individuals with intellectual disability*Journal of Intellectual Disability Research, 1997